Search research articles
Contact Us
Filters
Showing results (51-60 of 82) with videos related to
Page
of 9
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)
|
October 1, 1987
A synthetic peptide homologous to the envelope proteins of retroviruses inhibits monocyte-mediated killing by inactivating interleukin 1
E S Kleinerman, L B Lachman, R D Knowles, et al.
Oncology Research
|
January 1, 1992
Sequential therapy with chemotherapeutic drugs and liposome-encapsulated muramyl tripeptide: determination of potential interactions between these agents
J J Killion, E S Kleinerman, M R Wilson, et al.
American Journal of Clinical Oncology
|
April 1, 1995
Efficacy of liposomal muramyl tripeptide (CGP 19835A) in the treatment of relapsed osteosarcoma
E S Kleinerman, J B Gano, D A Johnston, et al.
Cancer Research
|
October 1, 1984
Constitutive production and release of a lymphokine with macrophage-activating factor activity distinct from gamma-interferon by a human T-cell leukemia virus-positive cell line
E S Kleinerman, R Zicht, P S Sarin, et al.
Journal of Leukocyte Biology
|
June 1, 1993
Mechanisms of Kupffer cell cytotoxicity in vitro against the syngeneic murine colon adenocarcinoma line MCA26
S A Curley, M S Roh, B Feig, et al.
Oncology Research
|
January 1, 1996
Transfection of a human topoisomerase II alpha gene into etoposide-resistant human breast tumor cells sensitizes the cells to etoposide
T Asano, T An, L A Zwelling, et al.
Cancer Research
|
May 1, 1983
Activation of tumoricidal properties in human blood monocytes by liposomes containing lipophilic muramyl tripeptide
E S Kleinerman, K L Erickson, A J Schroit, et al.
Cancer Research
|
August 15, 1989
Activation of tumoricidal properties in monocytes from cancer patients following intravenous administration of liposomes containing muramyl tripeptide phosphatidylethanolamine
E S Kleinerman, J L Murray, J S Snyder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 1992
Phase II study of liposomal muramyl tripeptide in osteosarcoma: the cytokine cascade and monocyte activation following administration
E S Kleinerman, S F Jia, J Griffin, et al.
Cancer Research
|
October 1, 1986
Activation or suppression of the tumoricidal properties of monocytes from cancer patients following treatment with human recombinant gamma-interferon
E S Kleinerman, R Kurzrock, D Wyatt, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 82) with videos related to
Sort By:
Page
of 9
Journal of Immunology (Baltimore, Md. : 1950)
|
October 1, 1987
A synthetic peptide homologous to the envelope proteins of retroviruses inhibits monocyte-mediated killing by inactivating interleukin 1
E S Kleinerman, L B Lachman, R D Knowles, et al.
Oncology Research
|
January 1, 1992
Sequential therapy with chemotherapeutic drugs and liposome-encapsulated muramyl tripeptide: determination of potential interactions between these agents
J J Killion, E S Kleinerman, M R Wilson, et al.
American Journal of Clinical Oncology
|
April 1, 1995
Efficacy of liposomal muramyl tripeptide (CGP 19835A) in the treatment of relapsed osteosarcoma
E S Kleinerman, J B Gano, D A Johnston, et al.
Cancer Research
|
October 1, 1984
Constitutive production and release of a lymphokine with macrophage-activating factor activity distinct from gamma-interferon by a human T-cell leukemia virus-positive cell line
E S Kleinerman, R Zicht, P S Sarin, et al.
Journal of Leukocyte Biology
|
June 1, 1993
Mechanisms of Kupffer cell cytotoxicity in vitro against the syngeneic murine colon adenocarcinoma line MCA26
S A Curley, M S Roh, B Feig, et al.
Oncology Research
|
January 1, 1996
Transfection of a human topoisomerase II alpha gene into etoposide-resistant human breast tumor cells sensitizes the cells to etoposide
T Asano, T An, L A Zwelling, et al.
Cancer Research
|
May 1, 1983
Activation of tumoricidal properties in human blood monocytes by liposomes containing lipophilic muramyl tripeptide
E S Kleinerman, K L Erickson, A J Schroit, et al.
Cancer Research
|
August 15, 1989
Activation of tumoricidal properties in monocytes from cancer patients following intravenous administration of liposomes containing muramyl tripeptide phosphatidylethanolamine
E S Kleinerman, J L Murray, J S Snyder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 1992
Phase II study of liposomal muramyl tripeptide in osteosarcoma: the cytokine cascade and monocyte activation following administration
E S Kleinerman, S F Jia, J Griffin, et al.
Cancer Research
|
October 1, 1986
Activation or suppression of the tumoricidal properties of monocytes from cancer patients following treatment with human recombinant gamma-interferon
E S Kleinerman, R Kurzrock, D Wyatt, et al.
Page
of 9